Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia

References

• Fialkow, P. J. (1976). Clonal origin of human tumors. Biochim. Biophys. Acta., 456, 283–321.
   Google Scholar
• Buick, R. N. and McCulloch, E. A. (1985). The role of stem cells in normal and malignant tissue. In: Control of animal cell proliferation: I, Boynton, A. L. and Leffert, H. L. (Eds.), pp. 25–57, Orlando, FL. Academic Press.
   Google Scholar
• Editor (1989). Stem cells in neoplasia. Lancet, 1, 701–702.
   PubMed Web of Science ®Google Scholar
• McCulloch, E. A. (1983). Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood, 62, 1–13.
   PubMed Web of Science ®Google Scholar
• Griffin, J. D. and Löwenberg, B. (1986). Clonogenic cells in acute myeloblastic leukemia. Blood, 68, 1185–1195.
   PubMed Web of Science ®Google Scholar
• Fialkow, P. J., Singer, J. W., Raskind, W. H., Adamson, J. W., Jacobson, R. J., Bernstein, I. D., Dow, L. W., Najfeld, V. and Veith, R. (1987). Clonal development, stem cell differentiation and clinical remissions in acute nonlymphocytic leukemia. N. Engl. J. Med., 317, 468–473.
   PubMed Web of Science ®Google Scholar
• Ogawa, M. (1993). Differentiation and proliferation of hematopoietic stem cells. Blood, 81, 2844–2853.
   PubMed Web of Science ®Google Scholar
• Ogawa, M., Porter, P. N. and Nakahata, T. (1983). Renewal and commitment to differentiation of hemopoietic stem cells (an interpretive review). Blood, 61, 823–829.
   PubMed Web of Science ®Google Scholar
• Morrison, S. J., Shah, N. M. and Anderson, D. J. (1997). Regulatory mechanism in stem cell biology. Cell, 88, 287–298.
   PubMed Web of Science ®Google Scholar
• Till, J. E., McCulloch, E. A. and Siminovitch, L. (1964). A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc. Natl. Acad. Sci. U.S.A., 51, 29–36.
   PubMed Web of Science ®Google Scholar
• Abkowitz, J. L., Catlin, S. N. and Guttorp, P. (1996). Evidence that hematopoiesis may be a stochastic process in vivo. Nature Med., 2, 190–197.
   PubMed Web of Science ®Google Scholar
• Trentin, J. J. (1976). Hematopoietic inductive microenvironments. In: Stem cells of renewing cell populations, Caimie, A. B., Lala, P. K. and Osmond, D. H. (Eds.), pp. 255–264, New York, NY, Academic Press.
   Google Scholar
• Leary, A. G., Ogawa, M., Strauss, L. C. and Civin, C. I. (1984). Single cell origin of multilineage colonies in culture: Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. J. Clin. Invest., 74, 2193–2197.
   PubMed Web of Science ®Google Scholar
• Humphries, R. K., Eaves, A. C. and Eaves, C. J. (1981). Self-renewal of hemopoietic stem cells during mixed colony formation in vitro. Proc. Natl. Acad. Sci. U.S.A., 78, 3629–3633.
   PubMed Web of Science ®Google Scholar
• Moore, M. A. S. (1991). Clinical implications of positive and negative hematopoietic stem cell regulators. Blood, 78, 1–19.
   PubMed Web of Science ®Google Scholar
• Nakahata, T. and Ogawa, M. (1982). Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J. Clin. Invest., 70, 1324–1328.
   PubMed Web of Science ®Google Scholar
• Nakahata, T. and Ogawa, M. (1982). Identification in culture of a class of hemopoietic colony-forming units with extensive capability of self-renew and generate multipotential hemopoietic colonies. Proc. Natl. Acad. Sci. US.A., 79, 3843–3847.
   PubMed Web of Science ®Google Scholar
• Ponchio, L., Conneally, E. and Eaves, C. (1995). Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factorstimulated entry into S phase in vitro. Blood, 86, 3314–3321.
   PubMed Web of Science ®Google Scholar
• McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M. and Weissman, I. L. (1988). The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science, 241, 1632–1639.
   PubMed Web of Science ®Google Scholar
• Lapidot, T., Pflumino, F., Doedens, M., Murdoch, B., Williams, D. E. and Dick, J. E. (1992). Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted into SCID mice. Science, 255, 1137–1141.
   PubMed Web of Science ®Google Scholar
• Dick, J. E. (1996). Normal and leukemic human stem cells assayed in SCID mice. Seminar Immunol., 8, 197–206.
   PubMedGoogle Scholar
• Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C. Y., Bhatia, M., Lapidot, T., Moritz, T., Murdoch, B., Xiao, X. L., Kato, I., Williams, D. A. and Dick, J. E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nature Med., 2, 1329–1337.
   PubMed Web of Science ®Google Scholar
• Zanjani, E. D., Pallavicini, M. G., Ascensao, J. L., Flake, A. W., Langlois, R. G., Reitsma, M., MacKintosh, F. R., Stutes, D., Harrison, M. R. and Tavassoli, M. (1992). Engraftment and long-term expression of human fetal hematopoietic stem cells in sheep following transplantation in utero. J. Clin. Invest., 89, 1178–1188.
   PubMed Web of Science ®Google Scholar
• Srour, E. F., Zanjani, E. D., Cometta, K., Traycoff, C. M., Flake, A. W., Hedrick, M., Brandt, J. E., Leemhuis, T. and Hoffman, R. (1993). Persistence of human multilineage lymphohematopoietic stem cells in chimeric sheep. Blood, 82, 3333–3342.
   PubMed Web of Science ®Google Scholar
• Sabbath, K. D., Ball, E. D., Larcom, P., Davis, R. B. and Griffin, J. D. (1985). Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J. Clin. Invest., 75, 746–753.
   PubMed Web of Science ®Google Scholar
• Lange, B., Ferrero, D., Pessano, S., Palumbo, A., Faust, J., Meo, P. and Rovera, G. (1984). Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies. Blood, 64, 693–700.
   PubMed Web of Science ®Google Scholar
• Löwenberg, B. and Bauman, J. G. J. (1985). Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers. Blood, 66, 1225–1232.
   PubMed Web of Science ®Google Scholar
• Till, J. E. and McCulloch, E. A. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Res., 14, 213–222.
   PubMed Web of Science ®Google Scholar
• Moore, M. A. S., Williams, N. and Metcalf, D. (1973). In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony-forming cells. J. Natl. Cancer Inst., 50, 603–623.
   PubMed Web of Science ®Google Scholar
• Dicke, K. A., Spitzer, G. and Aheam, M. J. (1976). Colony formation in vitro by leukemic cells in acute myelogenous leukemia with phytohemagglutinin as stimulating factor. Nature, 259, 129–130.
   PubMed Web of Science ®Google Scholar
• Buick, R. N., Till, J. E. and McCulloch, E. A. (1977). Colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet, 1, 862–863.
   PubMed Web of Science ®Google Scholar
• Minden, M. D., Buick, R. N. and McCulloch, E. A. (1979). Separation of blast cell and T-lymphocyte progenitors in the blood of patient with acute myeloblastic leukemia. Blood, 54, 186–195.
   PubMed Web of Science ®Google Scholar
• Kubota, K., Preisler, H. D., Sagawa, K. and Minowada, J. (1981). Comparison between agar and methylcellu- lose cultures of human leukemic cells. Cancer Res., 41, 3052–3057.
   PubMed Web of Science ®Google Scholar
• Ozawa, K., Miura, Y., Suda, T., Motoyoshi, K. and Takaku, F. (1983). In vitro differentiation of leukemic progenitor cells in various types of acute nonlymphocytic leukemia. Cancer Res., 43, 2334–2338.
   PubMed Web of Science ®Google Scholar
• Salem, M., Delwel, R., Mahmoud, L. A., Clark, S. and Elbasousy, E. M. (1989). Maturation of human acute myeloid leukemia in vitro: The response to five recombinant haematopoietic factors in a serum-free system. Br. J. Hematol., 71, 363–370.
   PubMed Web of Science ®Google Scholar
• Marie, J. P., Izaguirre, C. A., Civin, C. I., Mirro, J. and McCulloch, E. A. (1981). Granulopoietic differentiation in AML blasts in culture. Blood, 58, 670–674.
   PubMed Web of Science ®Google Scholar
• Löwenberg, B. and Touw, I. P. (1993). Hematopoietic growth factors and their receptors in acute leukemia. Blood, 81, 281–292.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Clark, S. C., Tsunematu, K., Shimizu, K., Park, J.-W., Ogawa, T. and Toyama, K. (1991). Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture. Leukemia, 5, 108–115.
   PubMed Web of Science ®Google Scholar
• Buick, R. N., Minden, M. D. and McCulloch, E. A. (1979). Self-renewal in culture of proliferative blast progenitor cells in acute meyloblastic leukemia. Blood, 54, 95–104.
   PubMed Web of Science ®Google Scholar
• McCulloch, E. A., Buick, R. N., Curtis, J. E., Messner, H. A. and Senn, J. S. (1981). The heritable nature of clonal characteristics in acute myeloblastic leukemia. Blood, 58, 105–109.
   PubMed Web of Science ®Google Scholar
• McCulloch, E. A., Kelleher, C. A., Miyauchi, J., Wang, C., Cheng, G. Y. N., Minden, M. D. and Curtis, J. E. (1988). Heterogeneity in acute myeloblastic leukemia. Leukemia, 2, 38S–49S.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Kelleher, C. A., Yang, Y.-C., Wong, G. G., Clark, S. C., Minden, M. D., Minkin, S. and McCulloch, E. A. (1987). The effects of three recombinant growth factors, IL-3, GM-CSF and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood, 70, 657–663.
   PubMed Web of Science ®Google Scholar
• Nara, N. and McCulloch, E. A. (1985). The proliferation in suspension of the progenitors of the blast cells in acute myeloblstic leukemia. Blood, 65, 1484–1493.
   PubMed Web of Science ®Google Scholar
• Sutherland, H. J., Blair, A. and Zapf, R. W. (1996). Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood, 87, 4754–4761.
   PubMed Web of Science ®Google Scholar
• Uckun, F. M. (1996). Severe combined immunodeficient mouse models of human leukemia. Blood, 88, 1135–1146.
   PubMed Web of Science ®Google Scholar
• Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A. and Dick, J. E. (1994). A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature, 367, 645–648.
   PubMed Web of Science ®Google Scholar
• Curtis, J. E., Messner, H. A., Hasselback, R., Elhakim, T. M. and McCulloch, E. A. (1984). Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia. J. Clin. Oncol., 2, 253–259.
   PubMed Web of Science ®Google Scholar
• Nara, N., Kurokawa, H., Tanikawa, S., Tomiyama, J. and Nagata, K. (1994). Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia. Cancer, 73, 92–97.
   PubMed Web of Science ®Google Scholar
• McCulloch, E. A., Curtis, J. E., Messner, H. A., Senn, J. S. and Germanson, T. P. (1982). The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood, 59, 601–608.
   PubMed Web of Science ®Google Scholar
• Hunter, A. E., Rogers, S. Y., Roberts, I. A. G., Barrett, A. J. and Russell, N. (1993). Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood, 82, 889–903.
   PubMed Web of Science ®Google Scholar
• Löwenberg, B., van Putten, W. L. J., Touw, I. P., Delwel, R. and Santini, V. (1993). Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N. Engl. J. Med., 328, 614–619.
   PubMed Web of Science ®Google Scholar
• Weisenthal, L. M., Marsden, J. A., Dill, P. L. and Macaluso, C. K. (1983). A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res., 43, 749–757.
   PubMed Web of Science ®Google Scholar
• Campling, B. G., Pym, J., Galbraith, P. R. and Cole, S. P. C. (1988). Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk. Res., 12, 823–831.
   PubMed Web of Science ®Google Scholar
• Schwarzmeier, J. D., Paietta, E., Mittermayer, K. and Pirker, R. (1984). Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro. Cancer, 53, 390–395.
   PubMed Web of Science ®Google Scholar
• Nara, N., Curtis, J. E., Senn, J. S., Tritchler, D. L. and McCulloch, E. A. (1986). The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood, 67, 762–769.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Hoang, T., Tritchler, D. and McCulloch, E. A. (1985). The effect of 5-azacytidine and its analogues on blast cell renewal in acute myeloblastic leukemia. Blood, 65, 894–901.
   PubMed Web of Science ®Google Scholar
• Park, C. H., Wiemik, P. H., Morrison, F. S., Amare, M., Van Sloten, K. and Maloney, T. R. (1983). Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res., 43, 2346–2349.
   PubMed Web of Science ®Google Scholar
• Preisler, H. D. and Azamia, N. (1984). Assessment of the drug sensitivity of acute non-lymphocytic leukaemia using the in vitro clonogenic assay. Br. J. Hematol., 58, 633–640.
   PubMed Web of Science ®Google Scholar
• Gustavsson, A. and Olofsson, T. (1984). Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. Cancer Res., 44, 4648–4652.
   PubMed Web of Science ®Google Scholar
• Marie, J. P., Zittoun, R. and Thevenin, D. (1988). In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia. Br. J. Cancer, 58, 570–574.
   PubMed Web of Science ®Google Scholar
• Nara, N. (1993). Prognostic significance of blast self-renewal capacity in acute myelocytic leukemia. Intl. J. Oncol., 3, 365–368.
   PubMed Web of Science ®Google Scholar
• McCulloch, E. A., Minden, M. D., Miyauchi, J., Kelleher, C. A. and Wang, C. (1988). Stem cell renewal and differentiation in acute myeloblastic leukemia. J. Cell. Sci., (suppl.), 10, 267–281.
   Google Scholar
• Smith, S. D., Uyeki, E. M. and Lowman, J. T. (1978). Colony formation in vitro by leukemic cells in acute lymphoblastic leukemia (ALL). Blood, 52, 712–718.
   PubMed Web of Science ®Google Scholar
• Izaquirre, C. A., Curtis, J., Messner, H. and McCulloch, E. A. (1981). A colony assay for blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia. Blood, 57, 823–829.
   PubMed Web of Science ®Google Scholar
• Touw, I., Delwel, R., Bolhuis, R., van Zanen, G. and Löwenberg, B. (1985). Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and inter-leukin 2 stimulates in vitro colony formation. Blood, 66, 556–561.
   PubMed Web of Science ®Google Scholar
• Stong, R. C. and Kersey, J. H. (1985). In vitro culture of leukemic cells in t(4; 11) acute leukemia. Blood, 66, 439–443.
   PubMed Web of Science ®Google Scholar
• Uckun, F. M., Kersey, J. H., Gajl-Peczalska, K. J., Heerema, N. A., Provisor, A. J., Haag, D., Gilchrist, G., Song, C. W., Arthur, D. C., Roloff, J., Lampkin, B., Greenwood, M., Dewald, G. and Vallera, D. A. (1987). Heterogeneity of cultured leukemic lymphoid progenitor cells from B-cell precursor acute lymphoblastic leukemia (ALL) patients. J. Clin. Invest., 80, 639–646.
   PubMed Web of Science ®Google Scholar
• Estov, Z. and Freedman, M. H. (1988). Growth requirements for human acute lymphoblastic leukemia cells: Refinement of a clonogenic assay. Cancer Res., 48, 5901–5907.
   PubMed Web of Science ®Google Scholar
• Hudson, A.-M., Makrynikola, V., Kabral, A. and Bradstock, K. F. (1989). Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay. Blood, 74, 2112–2120.
   PubMed Web of Science ®Google Scholar
• Ohyashiki, J. H., Ohyashiki, K., Miyauchi, J., Fujieda, H., Tauchi, T., Saito, M., Nakazawa, S., Kimura, N., Clark, S. C. and Toyama, K. (1992). Immunogenotypes and clonal culture analysis in B-precursor acute lymphoblastic leukemia. Leukemia, 6, 240–245.
   PubMed Web of Science ®Google Scholar
• Freedman, M. H., Grunberger, T., Correa, P., Axelrad, A. A., Dube, I. D. and Cohen, A. (1993). Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells. Blood, 81, 3068–3075.
   PubMed Web of Science ®Google Scholar
• Nishigaki, H., Ito, C., Manabe, A., Kumagai, M., Coustan-Smith, E., Yanishevski, Y., Behm, F. G., Raimondi, S. C., Pui, C. and Campana, D. (1997). Prevalence and growth characteristics of malignant stem cells in B-lineage acute lmphoblastic leukemia. Blood, 89, 3735–3744.
   PubMed Web of Science ®Google Scholar
• Campana, D., Coustan-Smith, E., Kumagai, M. and Manabe, A. (1994). Growth requirements of normal and leukemic human B-cell progenitors. Leuk. Lymphoma, 13, 359–371.
   PubMed Web of Science ®Google Scholar
• Hoang, T. and McCulloch, E. A. (1985). Production of leukemic blast growth factor by a human bladder carcinoma cell line. Blood, 66, 748–751.
   PubMed Web of Science ®Google Scholar
• Hoang, T., Haman, A., Goncalves, O., Letendre, F., Mathieu, M., Wong, G. G. and Clark, S. C. (1988). Interleukin-1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors. J. Exp. Med., 168, 463–474.
   PubMed Web of Science ®Google Scholar
• Hoang, T., Nara, N., Wong, G., Clark, S., Minden, M. D. and McCulloch, E. A. (1986). Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. Blood, 68, 313–316.
   PubMed Web of Science ®Google Scholar
• Souza, L. M., Boone, T. C., Gabrilove, J., Lai, P. H., Zsebo, K. M., Murdock, D. C., Chazin, V. R., Bruszewski, J., Lu, H., Chen, K. K., Barendt, J., Platzer, E., Moore, M. A. S., Mertelsmann, R. and Welte, K. (1986). Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science, 232, 61–65.
   PubMed Web of Science ®Google Scholar
• Delwel, R., Dorssers, L., Touw, I., Wagemaker, G. and Löwenberg, B. (1987). Human recombinant multilineage colony stimulating factor (Interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood, 70, 333–336.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Wang, C., Kelleher, C. A., Wong, G. G., Clark, S. C., Minden, M. D. and McCulloch, E. A. (1988). The effects of CSF-1 on the blast cells of acute myeloblastic leukemia in suspension culture. J. Cell. Physiol., 135, 55–62.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Kelleher, C., Wong, G. G., Yang, Y.-C., Clark, S. C., Minden, M. D. and McCulloch, E. A. (1988). The effects of combinations between recombinant growth factors GM-CSF, G-CSF, IL-3 and CSF-1 on the blast cells of acute myeloblastic leukemia. Leukemia, 2, 382–387.
   PubMed Web of Science ®Google Scholar
• Löwenberg, B., Salem, M. and Delwel, R. (1988). Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells, 14, 539–549.
   PubMedGoogle Scholar
• Imai, Y., Nara, N., Tohda, S., Nagata, K., Suzuki, T., Nagasawa, M., Murohashi, I. and Aoki, N. (1991). Antiproliferative and differentiative effects of recombinant interluekin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemia cell line. Blood, 78, 471–478.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Tohda, S., Nagata, K., Suzuki, T., Nara, N. and Aoki, N. (1991). Effects of recombinant interleukin-4 on the growth and differentiation of blast progenitors stimulated with G-CSF, GM-CSF and IL-3 from acute myeloblastic leukaemia patients. Br. J. Hematol., 78, 173–179.
   PubMed Web of Science ®Google Scholar
• Langley, G. R., Smith, L. J. and McCulloch, E. A. (1986). Adherent cells in cultures of blast progenitors in acute myeloblastic leukemia. Leukemia Res., 10, 953–959.
   PubMed Web of Science ®Google Scholar
• Vellenga, E., Ostapovicz, D., O'Rourke, B. and Griffin, J. D. (1987). Effects of recombinant IL-3, GM-CSF and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia, 1, 584–589.
   PubMed Web of Science ®Google Scholar
• Saeland, S., Caux, C., Favre, C., Aubry, J. P., Mannoni, P., Pebusque, M. J., Gentilhomme, O., Otsuka, T., Yokota, T., Arai, N., Arai, K., Banchereau, J. and de Vries, J. E. (1988). Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood, 72, 1580–1588.
   PubMed Web of Science ®Google Scholar
• Carlo-Stella, C., Mangoni, L., Almici, C., Frassoni, F., Fiers, W. and Rizzoli, V. (1990). Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Leukemia, 4, 561–566.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Takanashi, M., Masuda, M., Nakayama, K., Oshimi, K. and Mizoguchi, H. (1990). Colony stimulating activities of GM-CSF, G-CSF and IL-3 on blast progenitors from acute myeloblastic leukemia. Leukemia Lymphoma, 2, 407–414.
   PubMed Web of Science ®Google Scholar
• Murohashi, I., Endoh, K., Feng, M., Yoshida, K., Hirota, H., Yoshida, S., Jinnai, I., Bessho, M. and Hirashima, K. (1995). Roles of stem cell factor in the in vitro growth of blast clonogenic cells from patients with acute myeloblastic leukemia. J. Interferon Cytokine Res., 15, 829–835.
   PubMed Web of Science ®Google Scholar
• Griffin, J. D., Young, D., Herrmann, F., Wiper, D., Wagner, K. and Sabbath, K. D. (1986). Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood, 67, 1448–1453.
   PubMed Web of Science ®Google Scholar
• Vellenga, E., Young, D. C., Wagner, K., Wiper, D., Ostapovicz, D. and Griffin, J. D. (1987). The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood, 69, 1771–1776.
   PubMed Web of Science ®Google Scholar
• Asano, Y., Shibuya, T., Okamura, S., Yamaga, S., Otsuka, T. and Niho, Y. (1987). Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells. Cancer Res., 47, 5647–5648.
   PubMed Web of Science ®Google Scholar
• Kelleher, C., Miyauchi, J., Wong, G., Clark, S. C., Minden, M. D. and McCulloch, E. A. (1987). Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia. Blood, 69, 1498–1503.
   PubMed Web of Science ®Google Scholar
• Murohashi, I., Nagata, K., Suzuki, T., Maruyama, Y. and Nara, N. (1988). Effects of recombinant G-CSF and GM-CSF on the growth in methylcellulose and suspension of the blast cells in acute myeloblastic leukemia. Leuk. Res., 12, 433–440.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Takanashi, M., Fuchinoue, M., Masuda, M., Oshimi, K. and Mizoguchi, H. (1989). Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. Exp. Hematol., 17, 56–60.
   PubMed Web of Science ®Google Scholar
• Young, D. C. and Griffin, J. D. (1986). Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood, 68, 1178–1181.
   PubMed Web of Science ®Google Scholar
• Murohashi, I., Tohda, S., Suzuki, T., Nagata, K., Yamashita, Y. and Nara, N. (1989). Autocrine growth mechanism of the progenitors of blast cells in acute myeloblastic leukemia. Blood, 74, 35–41.
   PubMed Web of Science ®Google Scholar
• Pébusque, M.-J., Lafage, M., Lopez, M. and Mannoni, P. (1988). Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony-stimulating factor. Blood, 72, 257–265.
   PubMed Web of Science ®Google Scholar
• Nara, N., Murohashi, I., Suzuki, T., Yamashita, Y., Maruyama, Y., Aoki, N., Tanikawa, S. and Onazawa, Y. (1987). Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients. Br. J. Cancer, 56, 49–51.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Morio, T., Tohda, S., Nagata, K., Yamashita, Y., Imai, Y., Aoki, N., Hirashima, K. and Nara, N. (1990). Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients. Jpn. J. Cancer Res., 81, 979–986.
   PubMedGoogle Scholar
• Wang, C., Koistinen, P., Yang, G. S., Williams, D. E., Lyman, S. D., Minden, M. D. and McCulloch, E. A. (1991). Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia, 5, 493–499.
   PubMed Web of Science ®Google Scholar
• Ikeda, H., Kanakura, Y., Tamaki, T., Kuriu, A., Kitayama, H., Ishikawa, J., Kanayama, Y., Yonezawa, T., Tarui, S. and Griffin, J. D. (1991). Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood, 78, 2962–2968.
   PubMed Web of Science ®Google Scholar
• Broudy, V. C., Smith, F. O., Lin, N., Zsebo, K. M., Egrie, J. and Bernstein, I. D. (1992). Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood, 80, 60–67.
   PubMed Web of Science ®Google Scholar
• Carlesso, N., Pregno, P., Bresso, P., Gallo, E., Pileri, A., Zsebo, K. M. and Ferrero, D. (1992). Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia, 6, 642–648.
   PubMed Web of Science ®Google Scholar
• Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M. R., Ludwig, W.-D., Zsebo, K. and Welte, K. (1992). Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood, 80, 1199–1206.
   PubMed Web of Science ®Google Scholar
• Nara, N., Tanikawa, S., Nagata, K., Hamaguchi, H. and Tomiyama, J. (1993). Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia. Int. J. Hematol., 58, 27–35.
   PubMed Web of Science ®Google Scholar
• Budel, L. M., Delwel, R., Buitenen, C. V., Hoogerbrugge, H. and Löwenberg, B. (1993). Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Leukemia, 7, 426–434.
   PubMed Web of Science ®Google Scholar
• Inatomi, Y., Toyama, K., Clark, S. C., Shimizu, K. and Miyauchi, J. (1994). Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia. Cancer Res., 54, 445–462.
   Web of Science ®Google Scholar
• Siitonen, T., Lundström, M., Zheng, A., Savolainen, E. R. and Koistinen, P. (1996). Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia. Ann. Hematol., 73, 71–78.
   PubMed Web of Science ®Google Scholar
• Goselink, H. M., Williams, D. E., Fibbe, W. E., Wessels, H. W., Beverstock, G. C., Willemze, R. and Falkenburg, J. H. F. (1992). Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells. Blood, 80, 750–757.
   PubMed Web of Science ®Google Scholar
• Piacibello, W., Fubini, L., Sanavio, F., Brizzi, M. F., Severino, A., Garetto, L., Stacchini, A., Pegoraro, L. and Aglietta, M. (1995). Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood, 86, 4105–4114.
   PubMed Web of Science ®Google Scholar
• Lisovsky, M., Estrov, Z., Zhang, X., Consoli, U., Sanchez-Williams, G., Snell, V., Munker, R., Goodacre, A., Savchenko, V. and Andreeff, M. (1996). FLT3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of BCL-2 and bax. Blood, 88, 3987–3997.
   PubMed Web of Science ®Google Scholar
• Hoang, T., Haman, A., Goncalves, O., Wong, G. G. and Clark, S. C. (1988). Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood, 72, 823–826.
   PubMed Web of Science ®Google Scholar
• Akashi, K., Harada, M., Shibuya, T., Eto, T., Takamatsu, Y., Teshima, T. and Niho, Y. (1991). Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34− blasts from acute myelogenous leukemia. Blood, 78, 197–204.
   PubMed Web of Science ®Google Scholar
• Hu, J. P., Cesano, A., Santoli, D., Clark, S. C. and Hoang, T. (1993). Effects of inter-leukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood, 81, 1586–1592.
   PubMed Web of Science ®Google Scholar
• Lemoli, R. M., Fogli, M., Fortuna, A., Amabile, M., Zucchini, P., Grande, A., Martinelli, G., Visani, G., Ferrari, S. and Tura, S. (1995). Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells. Br. J. Hematol., 91, 319–326.
   PubMed Web of Science ®Google Scholar
• Pébusque, M.-J., Faÿ, C., Lafage, M., Sempéré, C., Saeland, S., Caux, C. and Mannoni, P. (1989). Recombinant human IL-3 and G-CSF act synergistically in stimulating the growth of acute myeloid leukemia cells. Leukemia, 3, 200–205.
   PubMed Web of Science ®Google Scholar
• Onetto-Pothier, N., Aumont, N., Haman, A., Park, L., Clark, S. C., De Léan, A. and Hoang, T. (1990). IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation. Leukemia, 4, 329–336.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Okada, M., Takanashi, M., Masuda, M. and Tanaka, K. (1990). Induction of eosinophilic colonies by interleukin-5 on acute myeloblastic leukaemic cells. Br. J. Haematol., 74, 169–172.
   PubMed Web of Science ®Google Scholar
• Ema, H., Kitano, K., Suda, T., Sato, Y., Muroi, K., Ohta, M., Yoshida, M., Sakamoto, S., Eguchi, M. and Miura, Y. (1990). In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). Blood, 75, 350–356.
   PubMed Web of Science ®Google Scholar
• Touw, I., Donath, J., Pouwels, K., van Buitenen, C., Schipper, P., Santini, V., Hagemeijer, A., Löwenberg, B. and Delwel, R. (1991). Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. Leukemia, 5, 687–692.
   PubMed Web of Science ®Google Scholar
• Baumann, M. A., Paul, C. C. and Grace, M. J. (1992). Effects of interleukin-5 on acute myeloid leukemias. Am. J. Hematol., 39, 269–274.
   PubMed Web of Science ®Google Scholar
• Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Horikawa, Y., Ishikawa, J., Kitayama, H., Nishiura, T., Tomiyama, Y., Miyazaki, H. and Matsuzawa, Y. (1996). The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood, 88, 3074–3082.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Takanashi, M., Motomura, S., Yan-Hua, W., Shiozaki, H., Aoyama, M. and Mizoguchi, H. (1996). Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia. Br. J. Haematol., 94, 513–516.
   PubMed Web of Science ®Google Scholar
• Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Ishikawa, J., Horikawa, Y., Hashimoto, K., Moriyama, Y., Tsujimura, T., Nishiura, T., Miyazaki, H. and Matsuzawa, Y. (1995). Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood, 86, 703–709.
   PubMed Web of Science ®Google Scholar
• Drexler, H. G. and Quentmeier, H. (1996). Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia, 10, 1405–1421.
   PubMed Web of Science ®Google Scholar
• Quentmeier, H., Zaborski, M., Graf, G., Ludwig, W. D. and Drexler, H. G. (1996). Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia, 10, 297–310.
   PubMed Web of Science ®Google Scholar
• Asano, Y., Okamura, S., Shibuya, T., Harada, M. and Niho, Y. (1988). Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood, 72, 1682–1686.
   PubMed Web of Science ®Google Scholar
• Motoji, T., Hoshino, S., Ueda, M., Takanashi, M., Masuda, M., Nakayama, K., Oshimi, K. and Mizoguchi, H. (1990). Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietin. Br. J. Haematol., 75, 60–67.
   PubMed Web of Science ®Google Scholar
• Tomonaga, M., Jinnai, I., Tagawa, M., Amenomori, T., Nishino, K., Yao, E., Nonaka, H., Kuriyama, K., Yoshida, Y., Matsuo, T., Ichimaru, M. and Suematsu, T. (1987). Leukemic blast cell colony formation in semisolid culture with erythropoietin: a case report of acute poorly differentiated erythroid leukemia. Blood, 69, 546–552.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Clark, S. C., Sugita, K., Okui, M., Taguchi, N. and Shimizu, K. (1991). Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study. J. Cell. Physiol., 148, 404–413.
   PubMed Web of Science ®Google Scholar
• Eder, M., Ottmann, O. G., Hansen-Hagge, T. E., Bartram, C. R., Gillis, S., Hoelzer, D. and Ganser, A. (1990). Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia. Leukemia, 4, 533–540.
   PubMed Web of Science ®Google Scholar
• Touw, I., Pouwels, K., van Agthoven, T., van Gurp, R., Budel, L., Hoogerbrugge, H., Delwel, R., Goodwin, R., Namen, A. and Löwenberg, B. (1990). Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood, 75, 2097–2101.
   PubMed Web of Science ®Google Scholar
• Digel, W., Schmid, M., Heil, G., Conrad, P., Gillis, S. and Porzsolt, F. (1991). Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood, 78, 753–759.
   PubMed Web of Science ®Google Scholar
• Dibirdik, I., Langlie, M. C., Ledbetter, J. A., TuelAhlgren, L., Obuz, V., Waddick, K. G., Gajl-Peczalska, K., Schieven, G. L. and Uckun, F. M. (1991). Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. Blood, 78, 564–570.
   PubMed Web of Science ®Google Scholar
• Ohyashiki, K., Miyauchi, J., Ohyashiki, J., Saito, M., Yaguchi, M., Inatomi, Y., Nakazawa, S., Wada, H., Mizutani, S., Matsuo, Y., Minowada, J. and Toyama, K. (1993). Interleukin-7 enhances colony growth and induces CD20 antigen of Ph+acute lymphoblastic leukemia cell line, OM9;22. Leukemia, 7, 1034–1040.
   PubMed Web of Science ®Google Scholar
• Nagasawa, T., Kikutani, H. and Kishimoto, T. (1994). Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. U.S.A., 91, 2305–2309.
   PubMed Web of Science ®Google Scholar
• Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H. and Kishimoto, T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacldng the CXC chemokine PBSF/SDF-1. Nature, 382, 635–638.
   PubMed Web of Science ®Google Scholar
• Touw, I., Delwel, R., Van Zanen, G., Löwenberg, B. (1986). Acute lymphoblastic leukemia and non-Hodgkin's lymphoma of T-lineage: Colony-forming cells retain growth factor (interleukin-2) dependence. Blood, 68, 1088–1094.
   PubMed Web of Science ®Google Scholar
• Georgoulias, V., Allouche, M., Salvatore, A., Clemeceau, G. and Jasmin, C. (1987). Interleukin-2 responsiveness of immature T-cell colony forming cells (T-CFC) from patients with acute lymphoblastic leukemias. Cell Immunol., 105, 317–331.
   PubMed Web of Science ®Google Scholar
• Wörmann, B., Gester, T. G., Mufsou, R. A. and Le Bien, T. W. (1989). Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia, 3, 399–404.
   PubMed Web of Science ®Google Scholar
• Wörmann, B., Mehta, S. R., Maizel, A. L. and Le Bien, T. W. (1987). Low-molecular weight B cell growth factor induces proliferation of human B-cell precursor acute lymphoblastic leukemias. Blood, 70, 132–138.
   PubMed Web of Science ®Google Scholar
• Delwel, R., van Buitenen, C., Salem, M., Bot, F., Gillis, S., Kaushansky, K., Altrock, B. and Löwenberg, B. (1989). Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release. Blood, 74, 586–593.
   PubMed Web of Science ®Google Scholar
• van der Schoot, C. E., Jansen, P., Poorter, M., Wester, M. R., von dem Borne, A. E. G. Kr., Aarden, L. A. and van Oers, R. H. J. (1989). Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood, 74, 2081–2087.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cimadevilla, J. C., Beauchemin, V., Villeneuve, L., Letendre, F., Shaw, A. and Hoang, T. (1990). Coordinate secretion of interleukin-lb and granulocytemacrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: Role of interleukin-1 as an endogenous inducer. Blood, 76, 1481–1489.
   PubMed Web of Science ®Google Scholar
• Bradbury, D., Rogers, S., Kozlowski, R., Bowen, G., Reilly, I. A. G. and Russell, N. H. (1990). Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia. Br. J. Haematol., 76, 488–493.
   PubMed Web of Science ®Google Scholar
• Bradbury, D., Bowen, G., Kozlowski, R., Reilly, I. and Russell, N. (1990). Endogeneous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF. Leukemia, 4, 44–47.
   PubMed Web of Science ®Google Scholar
• Delwel, R., van Buitenen, C., Salem, M., Oosterom, R., Touw, I. and Löwenberg, B. (1990). Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-a which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor. Leukemia, 4, 557–560.
   PubMed Web of Science ®Google Scholar
• Murohashi, I., Tohda, S., Suzuki, T., Nagata, K., Yamashita, Y. and Nara, N. (1993). Mechanism of action of interleukin-1 on the progenitors of blast cells in acute myeloblastic leukemia. Exp. Hematol., 18, 133–137.
   Google Scholar
• Brach, M. A., Löwenberg, B., Mantovani, L., Schwulera, U., Mertelsmann, R. and Herrmann, F. (1979). Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts. Blood, 76, 1972–1979.
   Google Scholar
• Wagteveld, A. J., Esselink, M. T., Limburg, P., Halie, M. R. and Vellenga, E. (1995). The effects of IL-1b and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells. Leukemia, 10, 1020–1024.
   Google Scholar
• Griffin, J. D., Rambaldi, A., Vellenga, E., Young, D. C., Ostapovicz, D. and Cannistra, S. A. (1987). Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood, 70, 1218–1221.
   PubMed Web of Science ®Google Scholar
• Vellenga, E., de Wolf, J. Th. M., Beentjes, J. A. M., Esselink, M. T., Smit, J.s W. and Halie, M. R. (1990). Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells. Blood, 75, 633–637.
   PubMed Web of Science ®Google Scholar
• Jansen, J. H., Fibbe, W. E., Wienjens, G. H., Willemze, R. and Kluin-Nelemans, J. C. (1993). Inhibitory effect of interleukin-4 on the proliferation of acute myeloid leukemia cells with myelomonocytic differentiation (AML-M4/M5); the role of interleukin-6. Leukemia, 7, 643–645.
   PubMed Web of Science ®Google Scholar
• Okabe, M., Kuni-eda, Y., Sugiwura, T., Tanaka, M., Miyagishima, T., Saiki, I., Minagawa, T., Kurosawa, M., Itaya, T. and Miyazaki, T. (1991). Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells. Blood, 78, 1574–1580.
   PubMed Web of Science ®Google Scholar
• Pandrau, D., Saeland, S., Duvert, V., Durand, I., Manel, A.-M., Zabot, M.-T., Philippe, N. and Banchereau, J. (1992). Interleukin-4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J. Clin. Invest., 90, 1697–1706.
   PubMed Web of Science ®Google Scholar
• Manabe, A., Coustan-Smith, E., Kumagai, M., Behm, F. G., Raimondi, S. C., Pui, C.-H. and Campana, D. (1994). Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood, 83, 1731–1737.
   PubMed Web of Science ®Google Scholar
• Bruserud, F. (1996). Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts. Leukemia, 10, 1497–1503.
   PubMed Web of Science ®Google Scholar
• Tuyt, L. M., Dokter, W. H., Esselink, M. T. and Vellenga, E. (1995). Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells. Eur. Cytokine Netw., 6, 231–235.
   PubMed Web of Science ®Google Scholar
• Jansen, J. H., Fibbe, W. E., Wientjens, G. J. H. M., Van Damme, J., Landegent, J. E., Willemze, R. and Kluin-Nelemans, J. C. (1991). Interleukin-4 down regulates the expression of CD14 and the production of interleukin-6 in acute myeloid leukemia cells. Lymphokine Cytokine Res., 10, 457–461.
   PubMedGoogle Scholar
• Lefort, S., Vita, N., Reeb, R., Caput, D. and Ferrara, P. (1995). IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. FEBS Lett., 366, 122–126.
   PubMed Web of Science ®Google Scholar
• Renard, N., Duvert, V., Banchereau, J. and Saeland, S. (1994). Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood, 84, 2253–2260.
   PubMed Web of Science ®Google Scholar
• Bruserud, F., Gjertsen, B. T., Brustugun, O. T., Bassøe, C. F., Nesthus, I., Akselsen, P. E., Bühring, H. J. and Pawelec, G. (1995). Effects of interleukin-10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia, 9, 1910–1920.
   PubMed Web of Science ®Google Scholar
• Cheng, G. Y. M., Kelleher, C. A., Miyauchi, J., Wang, C., Wong, G., Clark, S. C., McCulloch, E. A. and Minden, M. D. (1988). Structure and expression of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood, 71, 204–208.
   PubMed Web of Science ®Google Scholar
• Kobayashi, S., Teramura, M., Sugawara, I., Oshimi, K. and Mizoguchi, H. (1993). Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood, 81, 889–893.
   PubMed Web of Science ®Google Scholar
• Matsumura, I., Kanakura, Y., Ikeda, H., Ishikawa, J., Yoshida, H., Horikawa, Y., Nishiura, T., Tahara, T., Kato, T., Miyazaki, H. and Matsuzawa, Y. (1996). Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia, 10, 91–94.
   PubMed Web of Science ®Google Scholar
• Cozzolino, F., Rubartelli, A., Aldinucci, D., Sitia, R., Torcia, M., Shaw, A. and Guglielmo, R. D. (1989). Interleukin-1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. U.S.A., 86, 2369–2373.
   PubMed Web of Science ®Google Scholar
• Oster, W., Cicco, N. A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R. H. and Hermann, F. (1989). Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest., 84, 451–457.
   PubMed Web of Science ®Google Scholar
• Bruserud, F., Nesthus, I., Bühring, H.-J. and Pawelec, G. (1995). Cytokine modulation of interleukin-1 and tumor necrosis factor a secretion from acute myelogenous leukemia blast cells in vitro. Leukemia Res., 19, 15–22.
   PubMed Web of Science ®Google Scholar
• Dunbar, C. E., Browder, T. M., Abrams, J. S. and Nienhuis, A. W. (1989). COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science, 245, 1493.
   PubMed Web of Science ®Google Scholar
• Nara, N. and McCulloch, E. A. (1985). Membranes replace irradiated blast cells as growth requirement for leukemic blast progenitors in suspension culture. J. Exp. Med., 162, 1435–1443.
   PubMed Web of Science ®Google Scholar
• Overell, R. W., Clark, L., Lynch, D., Jerzy, R., Schmierer, A., Weisser, K. E., Namen, A. E. and Goodwin, R. G. (1991). Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine. Mol. Cell. Biol., 11, 1590–1597.
   PubMed Web of Science ®Google Scholar
• Estey, E. H. (1994). Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood, 83, 2015–2019.
   PubMed Web of Science ®Google Scholar
• Rowe, J. M., Anderson, J. W., Mazza, J. J., Bennet, J. M., Paietta, E., Hayes, F. A., Oette, D., Cassileth, P. A., Stadtmauer, E. A. and Wiernik, P. H. (1995). A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the eastern cooperative oncology group (E1490). Blood, 86, 457–462.
   PubMed Web of Science ®Google Scholar
• Stone, R. M., Berg, D. T., George, S. L., Dodge, R. K., Paciucci, P. A., Schulman, P., Lee, E. J., Moore, J. O., Powell, B. L. and Schiffer, C. A. (1995). Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New Engl. J. Med., 332, 1671–1677.
   PubMed Web of Science ®Google Scholar
• Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A. and Degos, L. (1995). A controlled study of recombinant human granulocyte colony-stimulating factor elderly patients after treatment for acute myelogenous leukemia. New Engl. J. Med., 332, 1678–1683.
   PubMed Web of Science ®Google Scholar
• Schiffer, C. A. (1996). Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia. Blood, 88, 3675–3685.
   PubMed Web of Science ®Google Scholar
• Geller, R. B. (1996). Use of cytokines in the treatment of acute myelocytic leukemia: a critical review. J. Clin. Oncol., 14, 1371–1382.
   PubMed Web of Science ®Google Scholar
• Geissler, K., Roller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knöbl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U., Heinz, R., Linkesch, W. and Lechner, K. (1997). Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia: a randomized phase-III study. Blood, 90, 590–596.
   PubMed Web of Science ®Google Scholar
• Pui, C.-H., Boyett, J. M., Hughes, W. T., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Synold, T., Relling, M. V., Ribeiro, R. C., Crist, W. M. and Evans, W. E. (1997). Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N. Engl. J. Med., 336, 1781–1787.
   PubMed Web of Science ®Google Scholar
• Minder, M. D., Till, J. E. and McCulloch, E. A. (1978). Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML). Blood, 52, 592–600.
   PubMed Web of Science ®Google Scholar
• Cannistra, S. A., Groshek, P. and Griffin, J. D. (1989). Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia. Leukemia, 3, 328–334.
   PubMed Web of Science ®Google Scholar
• Andreeff, M., Tafuri, A. and Hegewisch-Becker, S. (1990). Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside. Hematol. Blood Transfusion, 33, 747–762.
   PubMedGoogle Scholar
• Lista, P., Porcu, P., Avanzi, G. C. and Pegoraro, L. (1988). Interleukin-3 enhances the cytotoxic activity of 1-b-D-arabinofuranosylcytosine (Ara-C) on acute myeloblastic leukaemia (AML) cells. Br. J. Hematol., 70, 121–123.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Kelleher, C. A., Wang, C., Minkin, S. and McClloch, E. A. (1989). Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood, 73, 1272–1278.
   PubMed Web of Science ®Google Scholar
• Van der Lely, N., De Witte, T., Wessels, J., Raymakers, R., Muus, P. and Preijers, F. (1994). In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients; Factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity. Ann. Hematol., 68, 225–232.
   PubMed Web of Science ®Google Scholar
• Kanz, L., Brugger, W., Bross, K. and Mertelsmann, R. (1991). Combination of cytokines: Current status and future prospects. Br. J. Hematol., 79, 96–104.
   PubMed Web of Science ®Google Scholar
• Bhalla, K., Holladay, C., Arlin, Z., Grant, S., Ibrado, A. M. and Jasiok, M. (1991). Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts. Blood, 78, 2674–2679.
   PubMed Web of Science ®Google Scholar
• Lista, P., Brizzi, M. F., Rossi, M., Resegotti, L., Clark, S. C. and Pegoraro, L. (1990). Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment. Br. J. Hematol., 76, 21–26.
   PubMed Web of Science ®Google Scholar
• Koistinen, P., Wang, C., Curtis, J. E. and McCulloch, E. A. (1991). Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from Ara-C toxicity. Leukemia, 5, 789–795.
   PubMed Web of Science ®Google Scholar
• Hannum, Y. A. (1997). Apoptosis and the dilemma of cancer chemotherapy. Blood, 89, 1845–1853.
   PubMed Web of Science ®Google Scholar
• Sachs, L. and Lotem, J. (1993). Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood, 82, 15–21.
   PubMed Web of Science ®Google Scholar
• Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. and Sarfati, M. (1992). Interleukin-4 protects chronic lymphocytic leukemic B-cells form death by apoptosis and upregulates BCl-2 expression. J. Exp. Med., 176, 1319–1326.
   PubMed Web of Science ®Google Scholar
• Ohno, R., Kobayashi, T., Tanimoto, M., Hiraoka, A., Imai, K., Asou, N., Tomonaga, M., Tsubaki, K., Takahashi, I., Kodera, Y., Yoshida, M., Murakami, H., Naoe, T., Shimoyama, M., Tsukada, T., Takeo, T., Teshima, H., Onozawa, Y., Fujimoto, K., Kuriyama, K., Horiuchi, A., Kimura, I., Minami, S., Miura, Y., Kageyama, S., Tahara, T., Masaoka, T., Shirakawa, S. and Saito, H. (1993). Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. Cancer, 71, 3888–3895.
   PubMed Web of Science ®Google Scholar
• Hercus, T. R., Bagley, C. J., Cambareri, B., Dottore, M., Woodcock, J. M., Vadas, M. A., Shannan, M. F. and Lopez, A. F. (1994). Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc. Natl. Acad. Sci. U.S.A., 91, 5838–5842.
   PubMed Web of Science ®Google Scholar
• Iversen, P. O., To, L. B. and Lopez, A. F. (1996). Apoptosis of hematopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R. Proc. Natl. Acad. Sci. U.S.A., 93, 2785–2789.
   PubMed Web of Science ®Google Scholar
• Bhalla, K., Tang, C., Ibrado, A. M., Grant, S., Tourkina, E., Holladay, C., Hughes, M., Mahoney, M. E. and Huang, Y. (1992). Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood, 80, 2883–2890.
   PubMed Web of Science ®Google Scholar
• Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H. and Thompson, R. C. (1990). Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature, 343, 341–346.
   PubMed Web of Science ®Google Scholar
• Estrov, Z., Black, R. A., Sleath, P. R., Harris, D., Van, Q., LaPushin, R., Estey, E. H. and Talpaz, M. (1995). Effect of interleukin-1b converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation. Blood, 86, 4594–4602.
   PubMed Web of Science ®Google Scholar
• Schumann, R. R., Nakarai, T., Gruss, H. J., Brach, M. A., von Amim, U., Kirschning, C., Karawajew, L., Ludwig, W. D., Renauld, J. C., Ritz, J. and Herrmann, F. (1996). Transcript synthesis and surface expression of the interleukin-2 receptor (α-, β-, and γ-chain) by normal and malignant myeloid cells. Blood, 87, 2419–2427.
   PubMed Web of Science ®Google Scholar
• Lemoli, R. M., Fortuna, A., Tafuri, A., Fogli, M., Amabile, M., Grande, A., Ricciardi, M. R., Petrucci, M. T., Bonsi, L., Bagnara, G., Visani, G., Martinelli, G., Ferrari, S. and Tura, S. (1996). Interleukin-9 stimulates the proliferation of human myeloid leukemic cells. Blood, 87, 3852–3859.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Nagata, K., Murohashi, I. and Nara, N. (1988). Effect of recombinant human M-CSF on the proliferation of leukemic blast progenitors in AML patients. Leukemia, 2, 358–362.
   PubMed Web of Science ®Google Scholar
• Skjonsberg, C., Erikstein, B. K., Smeland, E. B., Lie, S. O., Funderud, S., Beiske, K. and Blomhoff, H. K. (1991). Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood, 77, 2445–2450.
   PubMed Web of Science ®Google Scholar
• Vinante, F., Rigo, A., Vincenzi, C., Ricetti, M. M., Marrocchella, R., Chilosi, M., Cassatella, M. A., Bonazzi, L. and Pizzolo, G. (1993). IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells. Leukemia, 7, 1552–1556.
   PubMed Web of Science ®Google Scholar
• Tobler, A., Moser, B., Dewald, B., Geiser, T., Studer, H., Baggiolini, M. and Fey, M. F. (1993). Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood, 82, 2517–2525.
   PubMed Web of Science ®Google Scholar